Wells Fargo & Company Danaher Corp Put Options Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$239.25 - $280.76 $574,200 - $673,824	2,400 New	2,400 $667,000
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $745,856 - $849,887	-3,200 Reduced 62.75%	1,900 $471,000
Q2 2023 Aug 15, 2023	SELL	$224.99 - $256.14 $247,489 - $281,754	-1,100 Reduced 17.74%	5,100 $1.22 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $1.32 Million - $1.52 Million	5,500 Added 785.71%	6,200 $1.56 Million
Q4 2022 Feb 13, 2023	BUY	$241.42 - $282.29 $144,852 - $169,374	600 Added 600.0%	700 $185,000
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $24,706 - $150,740	100 New	100 $26,000

2,511

539M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.